Home > PE Ratio > BAL PHARMA

BAL PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of BAL PHARMA is 26.33.

Share Price ₹121.7Apr 04,2025
Market Cap ₹193.5 Cr
Earnings-TTM₹7.3 CrTTM-Consolidated Results
Price/Earnings26.33xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BAL PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BAL PHARMA is calculated as :

Current Market Cap [ ₹193.5 Cr] as on Apr 04,2025

(/) Earnings [ ₹7.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 26.33x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BAL PHARMA , the investors are currently willing to pay 26.33 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAL PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BAL PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of BAL PHARMA


PE Ratio Performance Analysis for BAL PHARMA

- BAL PHARMA 's latest p/e ratio is 26.33x.

- BAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 21.13x.

- BAL PHARMA 's operated at median p/e ratio of 19.51x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2023 at 40.83x.

- BAL PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does BAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BAL PHARMA 7.3526.33193.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0035.71410,142.0
DIVIS LABORATORIES LTD2,067.0070.52145,762.0
CIPLA LTD5,000.4322.86114,322.0
TORRENT PHARMACEUTICALS LTD1,862.0059.71111,171.0
DR REDDYS LABORATORIES LTD5,428.6017.0692,603.7
MANKIND PHARMA LTD2,050.7349.30101,098.0
ZYDUS LIFESCIENCES LTD4,591.8018.9987,205.3
LUPIN LTD2,892.1031.1289,993.5
AUROBINDO PHARMA LTD3,500.2518.3364,167.0
ABBOTT INDIA LTD1,334.4646.2661,727.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAL PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.06x
Max industry PE 70.52x
Median industry PE 31.12x
Average industry PE 36.02x



You may also like the below Video Courses